[{"Assets_0_Q2_USD":1016861000.0,"CommonStockSharesOutstanding_0_Q2_shares":35894048.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":80635000.0,"NetIncomeLoss_1_Q2_USD":27455000.0,"NetIncomeLoss_2_Q2_USD":46653000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":35839000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":35772000.0,"StockholdersEquity_0_Q2_USD":658055000.0,"EarningsPerShareBasic_1_Q2_USD":0.76,"EarningsPerShareBasic_2_Q2_USD":1.3,"Ticker":"MEDP","CIK":"1668397","name":"MEDPACE HOLDINGS, INC.","OfficialName":"Medpace Holdings Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5256127036.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190730"}]